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Abstract 1 
Objectives: Patient medicines helpline services (PMHS) are available from some National Health 2 
Service (NHS) Trusts in the UK to provide medicines information to hospital patients and carers. To 3 
date, studies of PMHS have examined the views of service users via satisfaction surveys. This study 4 
used qualitative methods to explore service users’ experiences of using a PMHS, including perceived 5 
benefits and areas for improvement.  6 
Design: Qualitative, using semi-structured interviews. 7 
Setting: This study was conducted across seven NHS Trusts in England.  8 
Participants: Forty users of PMHS were individually interviewed over the telephone. Interviews were 9 
audio-recorded, transcribed verbatim, and analysed using Braun & Clarke’s inductive reflexive 10 
Thematic Analysis. Ethical approval was obtained before study commencement.  11 
Results: Participants predominantly called a PMHS for themselves (82%; carers: 18%). Two main themes 12 
were generated. Theme 1: Timeliness: PMHS provide support during the uncertain transition of care 13 
period from hospital to home, when patients and carers often feel vulnerable because support is less 14 
available. PMHS met service users’ needs for timely and easily accessible support, and quick resolution 15 
of their issues. PMHS could be improved with staffing beyond typical work week hours, and by having 16 
staff available to answer calls instead of using an answerphone. Theme 2: PMHS are best-placed to help: 17 
PMHS were perceived as best-placed to answer enquiries that arose from hospital care. Service users 18 
felt reassured from speaking to pharmacy professionals, and PMHS were perceived as the optimal 19 
service in terms of knowledge and expertise regarding medicines-related questions. However, several 20 
participants were initially unaware that their PMHS existed.  21 
Conclusions: PMHS are perceived to be a valuable means of accessing timely medicines-related support 22 
when patients and carers may be feeling particularly vulnerable. However, their availability and 23 
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promotion could be improved. We recommend that providers of PMHS consider whether this is 1 
achievable, in order to better meet the needs of service users. 2 
 3 
Keywords: Patients, carers, service users, medicines information, drug information services, patient 4 
medicines helpline services, hospital discharge, National Health Service, qualitative, thematic analysis.  5 
 6 
Strengths and limitations of this study 7 
• This is the first study to adopt an idiographic approach to exploring service users’ 8 
experiences of using patient medicines helpline service. 9 
• Participants were recruited from a geographically diverse range of NHS Trusts (n=7) across 10 
England. 11 
• Providers of the service acted as gatekeepers to participants, which may have resulted in 12 
participant selection bias. 13 
• The sample primarily comprised service users from acute NHS Trusts, and therefore could 14 
have been improved by additional service users from other Trust types (e.g., specialist and 15 
mental health). 16 
 17 
  18 
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BACKGROUND 1 
Many patients leave hospital with gaps in their knowledge about their medicines,1-6 and a 2 
sizeable number of patients subsequently experience medicines-related errors and require support 3 
with medicines-related problems.7-14 Consequently, hospital discharge may be a confusing and/or 4 
risky period for patients who have recently experienced changes to their medicines.  5 
Patient medicines helpline services (PMHS) have been set up at many National Health Service 6 
Trusts (NHS) in the United Kingdom with the aim of providing medicines-related support to recently 7 
discharged hospital patients and their carers. The first PMHS was set up in the UK in 1992, and a 8 
survey study conducted in 2017 reported that 52% of NHS Trusts provided a PMHS.15 Providing a 9 
PMHS accords with World Health Organisation (WHO) policy, which states that offering information 10 
on medicines via Medicines Information (MI) centres, and providing public education about 11 
medicines, are essential interventions to promote the rational use of medicines.16 12 
In line with healthcare quality improvement approaches, services are likely to be improved 13 
by seeking to understand the experiences of service users.17 In order to ascertain service users’ 14 
views and experiences of PMHS, quantitative satisfaction survey studies have been conducted, 15 
whereas qualitative studies have not.18 The results of such survey studies suggest that service users 16 
typically consider PMHS to be beneficial.18 For example, a recent systematic review found that 17 
satisfaction ratings are excellent, the advice received is reported to be usually followed, and users 18 
report several positive outcomes, such as feeling reassured, and improved health.18 However, a 19 
limitation of survey studies is that surveys include questions that are important to the researcher, 20 
rather than allowing participants to provide in-depth information that is important to them. 21 
Relatedly, survey answer options do not permit participants to respond in-depth using their own 22 
words. To enable service users to provide a detailed consideration of how and why PMHS may be 23 
beneficial and how they could be improved, an idiographic approach is needed.  24 
Running head: Patient medicines helpline services 
Page 5 of 26 
 
Whereas the nomothetic approach is considered useful for making generalisations about 1 
groups of individuals in order to make assumptions about populations, the idiographic approach is 2 
considered useful for exploring individuals’ lived experiences of a phenomenon.19 Idiography is 3 
concerned with exploring the in-depth experiences of particular individuals in particular contexts, 4 
and qualitative methods are considered appropriate for collecting rich data in order to achieve this.19 5 
Consequently, our study sought to address an important knowledge gap by being the first study to 6 
take an idiographic approach, and use qualitative methods, to explore service users’ experiences of 7 
PMHS.  8 
Aim 9 
The aim of this novel qualitative study was to explore patients’ and carers’ experiences of 10 
using a PMHS, their benefits, and ways that they can be improved. Through learning about patients’ 11 
and carers’ experiences of PMHS, we aimed to suggest improvements to how PMHS are delivered. In 12 
particular, this study addressed the following research question: What are patients’ and carers’ 13 
experiences of using an NHS patient medicines helpline service? 14 
METHOD 15 
Study design 16 
The authors adopted the epistemological position of pragmatism, in order to develop 17 
recommendations for service improvement for the benefit of users of PMHS. Pragmatism uses 18 
appropriate methods for solving practical problems, with an emphasis upon the usefulness of 19 
research.20 Pragmatism has become increasingly popular in health research, since its aim is to 20 
produce findings that are of benefit to service users.20-22 21 
For transparency, the study authors comprise three University academics with PhDs (one 22 
male, two female) and one PhD student with an MSc (male). All study authors have an interest in 23 
pharmacy practice, health services research, and/or health psychology. One author (MJ) has prior 24 
experience of managing a PMHS for an NHS Trust in England. 25 
Running head: Patient medicines helpline services 
Page 6 of 26 
 
Participants and recruitment 1 
  Recruitment was conducted via seven NHS Trusts from different regions within England: 2 
four acute Trusts, one mental health Trust, one specialist Trust, and one community Trust. Initially, 3 
four Trusts were recruited, one of each type. Additional Trusts of all types were subsequently 4 
recruited in order to ensure that our sample target was met, and to enhance the diversity of 5 
experiences included in the analysis. However, only three additional acute Trusts agreed to take 6 
part. Pharmacy professionals who provided the PMHS at sites acted as gatekeepers to the 7 
recruitment of participants, with each site recruiting participants over a six-month period.  8 
 Eligible participants were required to be either a patient, or a patient’s non-professional 9 
carer, who recently used a PMHS provided by an NHS Trust within England for the purpose of 10 
seeking support regarding medicines. Participants were also required to be aged 16 years or older, 11 
fluent in English, and available to participate in a telephone interview within one month of having 12 
used the PMHS. Participants were excluded if, in the pharmacy professional’s judgement, taking part 13 
would likely cause distress to the service user. Pharmacy professionals were also required to exclude 14 
service users who stated they were (or were considering) making a complaint against the Trust, and 15 
if the service user was a healthcare professional to the patient.  16 
 Invitations to participate in the study were sent from Trusts to all helpline enquirers who 17 
agreed to receive study information at the end of their call to the PMHS. After reading the study 18 
participant information sheet, interested individuals opted in by contacting the research team via 19 
telephone or email in order to participate. Prior to participation, interested individuals were 20 
informed as to the purpose of the study and what participation entailed, including key ethical issues 21 
(e.g., data storage and confidentiality). Interested individuals also had the opportunity to ask 22 
questions about the study. 23 
 Our estimated sample size was based upon that of published qualitative studies of service 24 
users’ experiences of healthcare services, and recommendations in literature.23 In relation to such 25 
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guidance, we aimed to conduct forty interviews. The sample size was not based upon reaching data 1 
saturation. The concept of data saturation has been challenged as a means of identifying the 2 
appropriate number of participants to include in a study.24 For example, it has been suggested that 3 
data may never be truly saturated, since there could always be potential codes and themes to be 4 
identified.25 5 
 The first forty individuals who contacted the study team and met the study eligibility criteria 6 
were recruited into the study. Prior to data collection, verbal informed consent was obtained from 7 
each participant via telephone, which is appropriate for low risk, telephone interview studies.26 8 
Data collection 9 
 Semi-structured interviews were chosen as the data collection method in order to provide 10 
flexibility through the use of probes and unplanned questions. This increased the potential for 11 
producing richer data compared with other approaches that were considered, such as a qualitative 12 
survey.23 Data were collected via telephone, enabling participants throughout England to be easily 13 
interviewed. Evidence suggests that telephone interviews can lead to rich data, provided that 14 
interviewers ensure that participants’ needs are understood and respected.27 28 Consequently, care 15 
was taken to ensure that participants were comfortable being interviewed over the telephone, and 16 
that they also felt able to pause the interview at any time and to ask clarification. Each participant 17 
was interviewed once.  18 
 During the same telephone call as the interview, but before the interview was conducted, 19 
the following background information was collected from participants: Name of NHS Trust 20 
contacted, date of PMHS contact, whether they had previously used a PMHS. Patients were also 21 
asked whether they were an inpatient or outpatient for their recent period of care, and the number 22 
of prescribed medicines they were prescribed at the time of the PMHS contact. Carers were also 23 
asked their relationship to the patient who the PMHS contact was regarding. 24 
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 Separate interview schedules were developed for patients and carers (see Supplementary 1 
file 1 for the interview schedules). Table 1 provides a summary of the interview topics (e.g. what the 2 
patient/carer found helpful and unhelpful about their experience of contacting the PMHS). The 3 
interview schedules were broadly similar, although, for ethical reasons, the carer version did not 4 
contain questions that would have resulted in them providing personal information about the 5 
individual in their care. The aim of the interview with carers was to explore whether the PMHS met 6 
their needs as a carer seeking information. Both schedules comprised open-ended questions, and 7 






Table 1. Topics for the interviews with service users 
Topics for interviews with service users 
1. Why the patient/carer contacted the helpline service, including what their question 
or concern was, the perceived seriousness of the issue, whether they considered any 
other sources of medicines information, and their decision-making process for 
choosing to use the helpline service.  
2. What the patient/carer found helpful and unhelpful about their experience of 
contacting the medicines helpline service. 
3. What impact the patient's/carer's use of the service has had (e.g., Was the advice 
followed? If so, what were the outcomes of this? If the advice was not followed, what 
were the reasons for this?). 
4. Whether there were any self-perceived negative consequences of using the helpline 
service. 
5. How the patient/carer felt about the medicines now, compared to before the 
helpline contact. 
6. How the patient/carer felt about the hospital and NHS Trust now, compared to 
before the helpline contact. 
7. What the patient/carer would have done had the helpline service not been 
available, and why. 
8. Whether the patient/carer sought any other sources of medicines-related 
information or support following their use of the helpline service, and if so, why. 
 14 
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 1 
 During data collection, the interview schedules served as flexible guides for interviews, 2 
enabling participants to discuss aspects of their experiences of using a PMHS that were important to 3 
them.  4 
 During the same telephone call as the interview, but after their interview had been 5 
conducted, the following background data were collected from each participant: age, gender, 6 
ethnicity, and current occupational status. 7 
 All interviews were conducted by a trained interviewer (MW), audio-recorded, and 8 
transcribed verbatim. 9 
Data analysis 10 
 Braun and Clarke’s inductive reflexive thematic analysis (TA) was used to analyse the 11 
qualitative interview data.32 33 TA is a systematic, rigorous and transparent technique for organising, 12 
describing, and interpreting data, which has been used within health research to explore patients’ 13 
experiences of healthcare services.34-36 Braun & Clarke’s TA was chosen instead of other thematic 14 
methods, since it provides a straight-forward step-by-step process for conducting a thorough and 15 
transparent analysis. 16 
 Analysis involved the following stages, as outlined by Braun and Clarke: familiarisation with 17 
the data, generating initial codes, developing themes, reviewing themes, defining and naming 18 
themes, and writing the analysis.23 32 Individual interview transcripts were uploaded into NVivo 19 
version 12,37 which was used for generating initial codes and developing and reviewing themes. The 20 
only deviation to the TA stages was that Iterative Categorisation (IC) was used in place of the 21 
defining themes stage.38 The choice to use IC was made in order to increase transparency and rigour. 22 
IC is also a systematic, rigorous and transparent technique, which can be used to support a range of 23 
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analytical techniques, including TA .38 IC leaves a clear audit trail, which provides a route back to the 1 
coded data (see Neale for further details).38  2 
Patient and public involvement 3 
 The study design and documents (participant information sheet and interview schedules) 4 
were reviewed by six members of the public who were either recent hospital patients or carers. 5 
Refinements to the documents were made based upon their feedback. Patients/the public were not 6 
involved in the recruitment of participants, nor dissemination of findings. 7 
Establishing quality in qualitative research 8 
Yardley’s criteria for demonstrating the quality of qualitative research were met 39. For 9 
sensitivity to context, previous literature was reviewed in preparation for the study, and we 10 
endeavoured to recruit participants from several different NHS Trusts. For commitment and rigour, 11 
TA and IC stages were followed, including Braun & Clarke’s 15-point guidelines on conducting TA,23 12 
and a ‘paper trail’ approach was used. Also, credibility checks were conducted, where each stage of 13 
the analysis was checked by another member of the research team to verify that the identified codes 14 
and themes were appropriate. Additionally, the consolidated criteria for reporting qualitative 15 
research (COREQ) and the standards for reporting qualitative research (SRQR) were followed.40 41 For 16 
coherence and transparency, the study results are grounded in example quotations from the raw 17 
data. A reflective diary was used throughout the process of data collection and analysis, to record 18 
thoughts about each interview, contextual features that may have influenced interviews, and/or any 19 
ways that interviews could have been improved in order to enhance subsequent interviews. 20 
Additionally, the authors have disclosed their positions regarding the research topic. For impact and 21 
importance, the study findings were used to develop recommendations for improving the provision 22 
of PMHS.  23 
RESULTS 24 
Participant characteristics 25 
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Table 2 provides an overview of participant characteristics (see Supplementary file 2 for 1 
anonymised information regarding each participant). Participants were predominantly, female, 2 
elderly, had used a PMHS regarding themselves, and had used a PMHS that was based at an acute 3 
Trust. Table 3 provides an overview of the types of enquiries that participants made to the PMHS.  4 
  5 
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Table 2. Participant characteristics 
Characteristic 
Participants (n = 40) 
n (%), or mean years 
(SD; range) 
   
Type of enquirer Patient, calling for self 33 (82%) 
 Carer / calling on behalf of patient 7 (18%) 
   
Type of patient a Inpatient 17 (52%) 
 Outpatient 12 (36%) 
 Member of the public 4 (12%) 
   
Type of carer b Spouse or partner of patient 5 (71%) 
 Parent of patient 1 (14%) 
 Son or daughter of patient 1 (14%) 
   
No. medicines currently prescribed a Zero to 4 11 (33%) 
 5 to 9 19 (58%) 
 10 or more 3 (9%) 
   
Gender of enquirer Male 17 (42%) 
 Female 23 (58%) 
   
Age of enquirer (years)  68 (9.87; 44 to 85) 
   
Ethnicity of enquirer White or White British 38 (95%) 
 Asian or Asian British 1 (3%) 
 Mixed race 1 (3%) 
   
Occupational status of enquirer Retired 30 (75%) 
 Employed 4 (10%) 
 Unemployed 4 (11%) 
 Carer and/or homemaker 2 (5%) 
   
Has enquirer used PMHS in the past? No 34 (85%) 
 Yes 6 (15%) 
   
NHS Trust type where PMHS was used Acute 1 23 (57.5%) 
 Acute 2 6 (15%) 
 Acute 3 6 (15%) 
 Acute 4 3 (7.5%) 
 Mental health 1 (2.5%) 
 Specialist 1 (2.5%) 
 Community 0 (0%) 
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Note. Abbreviations: NHS = National Health Service; PMHS = patient medicines helpline service. 
a Data collected only from participants who were patients 




Table 3. Types of enquiries made by study participants (n = 40) 
Enquiry type n (%) 
  
Administration or dosage 10 (25%) 
Interaction 9 (23%) 
Supply 7 (18) 
Medicines-related error a 6 (15%) 
Side effects 6 (15%) 
Storage 2 (5%) 
    
a Incorrect medicine prescribed (n = 3); missing medication (n = 2); 
discharge paperwork not sent to primary care, causing a delay to 




Interview duration 7 
Interview duration ranged from 12 to 66 minutes (mean = 25 minutes).   8 
Overview of themes 9 
Two main themes were generated from the analyses: Timeliness, and PMHS are best-placed 10 
to help. Timeliness identifies that service users often feel vulnerable after discharge from secondary 11 
care, and that service users want quick access to support when they need it, from pharmacy 12 
professionals who are available to help them. This is what PMHS have the potential to provide, 13 
although their availability could be improved. PMHS are best-placed to help reveals that PMHS may 14 
reduce the burden upon other healthcare services, and that PMHS are considered to be the best 15 
place to access medicines-related support pertaining to hospital care, from pharmacy professionals 16 
Running head: Patient medicines helpline services 
Page 14 of 26 
 
with expert knowledge. Pharmacy professionals were considered to have positive personal qualities 1 
that helped to reassure service users. However, although PMHS are considered best-placed to help, 2 
service users’ awareness of the existence of PMHS could be improved. 3 
Theme 1: Timeliness 4 
Vulnerable after discharge 5 
Participants described feeling vulnerable after leaving hospital, and in need of support during 6 
this transition of care period. Reasons for feeling vulnerable after leaving hospital included being in 7 
recovery, feeling isolated, being house-bound, experiencing a medicines-related error (e.g., a 8 
missing medication), being discharged with multiple medicines and feeling confused, and realising 9 
that they had not asked important questions during discharge. The PMHS was perceived to fulfil this 10 
important service gap. 11 
“If you’ve been discharged from hospital, for instance, you’re given a bunch of medicines, it’s 12 
explained to you, and perhaps you don’t absorb it all completely… It probably just doesn’t quite go in 13 
until you come home… and then you think “Ah. Perhaps I should’ve asked this question.” In which 14 
case, if you’ve got something like this helpline, it’s invaluable.” (P11, Male, Patient) 15 
Accessing help 16 
Pertaining to feeling vulnerable after leaving hospital, participants perceived the situation as 17 
stressful, and spoke of the need for immediate help with regards to medication advice. In order to 18 
reduce this stress, it was therefore important to be able to access support quickly (i.e., no 19 
answerphone or additional buttons to press to get through), and to also have the situation resolved 20 
as soon as possible. This is what the PMHS typically enabled.  21 
“I was relieved, actually, to have somebody to talk to immediately that could help me within a 22 
short space of time.” (P5, Female, Patient) 23 
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Participants spoke of the importance of the method of accessing the PMHS, and that the 1 
telephone was vital for accessing the service quickly, compared to accessing the service via email. 2 
Access methods were often described in relation to participants’ perceived severity of the situation 3 
(i.e., email would be useful for situations where help was not needed immediately).  4 
“I think it depends on the urgency of the situation… Because of this situation, [telephone access] 5 
was great. It was immediate… but if it wasn’t a vital thing, then yes…I could just email it through 6 
thinking “I don’t even need it today, this minute, but in the next couple of days would be helpful.”” 7 
(P32, Female, Carer) 8 
Relatedly, some participants commented that potential access options, such as online chat or a 9 
mobile phone app, would increase their stress.  10 
“I’m not that keen on technology. At a time when I felt really stressed out, I would’ve had an 11 
added stressor, having to work out how to do it. So, for me, it’s very comforting, because I’m very 12 
familiar with the telephone [laughs].” (P10, Female, Patient) 13 
However, participants felt that having more than one method of accessing support is useful, 14 
such as telephone and email. Several participants considered the access options of email, online 15 
chat, and mobile phone app to likely be preferable for younger service users.  16 
Availability of help 17 
Participants described how contacting the PMHS was likely to lead to a quicker resolution in 18 
comparison to other sources of support (e.g., their GP, a local pharmacy, NHS 111, or another 19 
hospital contact). This was another reason why participants typically contacted the PMHS in the first 20 
instance. 21 
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“I was waiting to hear back from the surgery, because I left it with the receptionist at the 1 
surgery… But actually, I only got a call from the surgery this morning. And this was resolved [by the 2 
PMHS], you know, last week.” (P16, Female, Patient) 3 
Although most participants described their PMHS as timely, some were concerned about 4 
needing the service when it was unavailable (e.g., evenings and weekends, to support patients who 5 
get discharged out-of-hours, and people who are unable to contact the service during typical work 6 
hours).  7 
“Seven days a week would improve it. If you were discharged on the Friday night, being in the 8 
situation I was in, I would’ve been very concerned.” (P9, Female, Patient) 9 
Additionally, only one participant had a negative experience of contacting a PMHS, when they 10 
contacted the service for a second time. Here, the helpline team were not available to take the call. 11 
The participant left a message on the PMHS answerphone and was not called back.  12 
“I’m wondering if… a vulnerable patient was calling hoping to get some kind of reassurance,… 13 
and left a message and they weren’t called back, they would mistrust this service.” (P6, Female, 14 
Patient) 15 
Theme 2: PMHS are best-placed to help 16 
Reduced burden upon other services 17 
Participants considered their PMHS to be best-placed to help for several reasons. Primarily, 18 
participants spoke of the importance of returning to the place where they recently received care, 19 
rather than seeking advice elsewhere. Many participants felt that they would contact the hospital 20 
anyway, had the PMHS not existed. 21 
 “As far as I was concerned. I’d just left the hospital, so I reckoned they [PMHS] would know.” 22 
(P28, Female, Patient) 23 
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There was recognition that contacting the PMHS could reduce the burden upon other healthcare 1 
services, or that queries may have gone unasked, since some participants described not wanting to 2 
burden other healthcare services. PMHS providers were perceived as having more time to answer 3 
queries compared to other HCPs, particularly hospital consultants and GPs. 4 
“Hospitals and doctors are extremely busy, and some of the queries you might have might be 5 
very trivial, and take up time, which is not the best use of the medical practitioners’ time. Some of 6 
those issues, if you can deal with a call to this helpline, then I think it’s in everybody’s best interest.” 7 
(P31, Male, Patient) 8 
A source of expertise 9 
Participants spoke of the PMHS having the knowledge and resources to deal with enquiries 10 
that other HCPs would not necessarily have (e.g., access to medical records; an overview of their 11 
multiple health conditions and medicines regimen). 12 
 “There’s no point ringing up the doctor. Because they aren’t specialised in all this treatment, you 13 
know. So that’s why we rang the [PMHS].” (P1, Female, Carer) 14 
Relatedly, participants described the benefit of speaking to a pharmacy professional regarding 15 
their medicines, since pharmacists are experts about medication and their advice can be trusted. 16 
Participants often described this as providing them with the reassurance needed to take their 17 
medicines as advised, particularly when taking multiple medicines, when the potential for mistakes 18 
is increased. 19 
“To make sure that whatever you’re proposing to do has at least been under the eye of a 20 
pharmacist, makes you feel reassured that you’re not doing anything that you shouldn’t.” (P21, Male, 21 
Patient) 22 
Positive personal qualities 23 
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Participants also spoke of helpline staff as having positive personal qualities, which were 1 
important for providing them with reassurance at a time when they felt anxious. Several participants 2 
compared the positive experience with the helpline staff to less positive experiences with other 3 
HCPs (e.g., their GP). Positive personal qualities of helpline staff included being professional, calm, 4 
compassionate, down to earth, having good listening and communication skills, being 5 
knowledgeable and confident, being thorough, going above and beyond what they wanted, not 6 
being dismissive, and working with the patient to devise a plan to support them.  7 
 “The person who I dealt with, she listened, she was compassionate, she normalised how I was 8 
feeling, and then in order to help alleviate the distress that I felt she made a plan that would reduce 9 
the distress that I was feeling. And it was a really really positive experience.” (P37, Male, Patient) 10 
Helpful but hidden 11 
 Although PMHS were considered best-placed to help, awareness of the service was 12 
sometimes poor. A number of participants described how they were not initially aware that the 13 
PMHS existed (e.g., they called the hospital and were transferred to the PMHS). There was 14 
recognition that PMHS should be promoted more, since they are considered beneficial and could 15 
help a greater number of patients. 16 
 “I wasn’t aware it was available… So I think the more that they can let people know that the 17 
service is available, the better.” (P36, Female, Carer) 18 
 Suggestions for improving promotion of PMHS included pharmacy professionals visiting 19 
wards to tell patients about it, putting posters up around the hospital and in the local area (GP 20 
surgeries, local pharmacies), and advertising within discharge summaries. However, one participant 21 
struggled to find the contact details within their discharge summary, and was initially unsure what 22 
the service provided because the promotion was unclear.  23 
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 “Almost put a bit more higher priority… Because it was buried along in page three or five. I 1 
wouldn’t have known how I could use that service, or if it was a priority I could use them, or whether I 2 
should try other routes before I use them.” (P32, Female, Carer) 3 
DISCUSSION 4 
This study explored forty service users’ experiences of using an NHS PMHS. Two themes 5 
were identified during the analysis: Timeliness, and PMHS are best-placed to help. The findings 6 
illustrate how PMHS meet patients’ and carers’ needs for timely and easily accessible support, and 7 
for enquiries to be quickly resolved. However, PMHS may not always be considered a timely source 8 
of support, since the service is not available all the time. PMHS could therefore be improved by 9 
being available during evenings and at weekends. Additionally, providing a PMHS with an 10 
answerphone will mean that service users will experience a delay to receive help, and there may be 11 
a risk that messages are missed. PMHS were perceived to be uniquely placed to answer medication 12 
queries that arose from hospital care, and were more positively viewed as approachable and 13 
valuable when compared with other sources, such as GPs. However, several participants were 14 
initially unaware that the service existed, and so, increasing the promotion of PMHS would ensure 15 
that more patients have access to timely help when it is needed. Relatedly, increasing the promotion 16 
of PMHS will only be useful if the promotional materials are clear as to who the service is for, and 17 
what the service provides. 18 
Our findings accord with those of a recent systematic review and a literature review that 19 
examined the evidence regarding the effectiveness of medicines information services for patients 20 
and the general public, both within the UK and internationally.18 42 Based upon survey study findings, 21 
the systematic review concluded that such services are typically perceived positively by service users 22 
(e.g., satisfaction ratings are excellent), and users report several positive outcomes such as feeling 23 
reassured.18 Our qualitative study found that PMHS provide reassurance to service users during the 24 
transition of care period when service users may be feeling particularly vulnerable. Their anxieties 25 
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were alleviated by having quick access to an expert who had the skills to address their enquiries 1 
efficiently and compassionately.  2 
Our findings also are consistent with two survey studies examining the provision of PMHS in 3 
the UK.15 43 The most recent of these was conducted in 2017, and surveyed all NHS Trusts in England 4 
in order to examine whether Royal Pharmaceutical Society endorsed national standards for 5 
providing a PMHS were being met.15 44 This survey identified that both the availability and promotion 6 
of PMHS were below standard. For example, out of 117 Trusts that provided a PMHS, only 57% 7 
reported that their PMHS was available for eight or more hours per day, and only 7% reported that 8 
their PMHS was available out-of-hours, such as during evenings and weekends. Additionally, only 9 
40% of Trusts used promotional material describing PMHS access times and the types of enquiries 10 
that patients/carers can make. Under-promotion was also identified as an issue in a recently 11 
conducted qualitative study exploring thirty-four pharmacy professionals’ perceptions of providing 12 
PMHS.45 Under-promotion was perceived by pharmacy professionals as a reason why PMHS are 13 
underused. Additionally, some pharmacy professionals described how their PMHS is under-14 
promoted for fear of not being able to cope with the demand due to lack of resources to adequately 15 
deliver the service. Promotion of PMHS is important because if patients do not know that the service 16 
exists, they cannot utilise it, thus the opportunity to resolve medicines-related issues is missed. This 17 
may result in harm to patients. An evaluation of 500 calls to one PMHS at an acute NHS Trust found 18 
that 48% of issues may have resulted in patient harm had professional information from the helpline 19 
not been available.46  20 
Recommendations for practice 21 
Study findings suggest that to better meet the needs of the service users, the provision of PMHS 22 
could be improved by extending their opening hours so that they are available during evenings and 23 
weekends. Providers should also ensure that helpline staff are available to answer the telephone rather 24 
than using answerphones. The promotion of the service could be improved to increase knowledge of 25 
the service among patients and carers. Such promotion could include ward pharmacists telling their 26 
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patients and patients’ carers about the PMHS during ward rounds, and by advertising the PMHS clearly 1 
in patients’ copies of their discharge summaries. However, we appreciate that the above 2 
recommendations may be challenging since PMHS are often established without funding and are often 3 
provided within a resource-limited context.43 45 Because our findings described in this study and in a 4 
recently conducted systematic review suggest that PMHS can have several benefits for patients,18 5 
budget holders/commissioners should consider whether they should fund new PMHS. This is important, 6 
since a survey study conducted in 2017 reported that only 52% of NHS Trusts provided a PMHS.15 7 
Recommendations for future research 8 
Future research is needed to better understand the needs of patients and carers when 9 
contacting a PMHS, particularly pertaining to service availability, methods of access, and promotion. 10 
One option could be to conduct a large, prospective, multi-site mixed methods survey, with enquirers of 11 
all ages, in order to enhance the generalisability of the findings. Another option could be to conduct a 12 
discreet choice experiment in order to elicit potential service users’ preferences regarding the provision 13 
of PMHS, such as the availability, access, and promotion of the service. Further research is also needed 14 
to explore the experiences of patients and carers who have problems or queries regarding medicines 15 
following hospital discharge, yet do not contact their Trust’s PMHS. This may result in additional 16 
recommendations to improve the awareness and use of PMHS.  17 
Strengths and limitations 18 
This is the first study to take an idiographic approach to exploring service users’ perceptions of 19 
PMHS, thereby providing rich and contextualised accounts of PMHS use that have resulted in 20 
recommendations for service improvement and future research endeavours. Service users were 21 
recruited from seven NHS Trusts from different regions within England in order to include a broad range 22 
of experiences of PMHS use. Additionally, consideration was made throughout the study to enhance the 23 
validity and trustworthiness of the findings. However, providers of the service acted as gatekeepers to 24 
participants, which may have resulted in selection bias. Furthermore, the sample predominantly 25 
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comprised service users from acute NHS Trusts, and therefore could have been improved by the 1 
addition of service users from other Trust types (e.g., mental health, specialist, and community Trusts). 2 
Finally, the sample may also be limited since participants had already chosen to contact a PMHS and 3 
may therefore be likely to hold positive views about telephone helplines.  4 
Conclusion 5 
PMHS are seen as a valuable means of easily accessing timely medicines-related support during 6 
a transfer of care period, when patients and carers may be feeling particularly vulnerable. PMHS were 7 
perceived as best-placed to answer enquiries that arose from hospital care. PMHS were also perceived 8 
as the optimal service in terms of knowledge and expertise with regard to answering questions about 9 
medications. However, the availability and promotion of PMHS could be improved. We recommend that 10 
providers of PMHS consider whether this is achievable, in order to better meet the needs of service 11 
users.  12 
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